Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Roden

Showing results (51-60 of 1,010) with videos related to

Pageof 101
Sort By:
Journal of the American College of Cardiology|February 4, 2014
Atrial fibrillation genomics: time to take the next stepDan M Roden
Archives of Internal Medicine|March 1, 1985
Tocainide and mexiletine. Orally effective lidocaine analoguesD M Roden
Circulation|January 26, 2005
An underrecognized challenge in evaluating postmarketing drug safetyDan M Roden
Pacing and Clinical Electrophysiology : PACE|December 17, 2003
Antiarrhythmic drugs: past, present, and futureDan M Roden
The New England Journal of Medicine|March 5, 2004
Drug-induced prolongation of the QT intervalDan M Roden
Epilepsia|March 13, 2002
Principles in pharmacogeneticsD M Roden
Journal of Internal Medicine|December 13, 2005
Long QT syndrome: reduced repolarization reserve and the genetic linkD M Roden
The American Journal of Cardiology|November 26, 1993
Pharmacokinetics of amiodarone: implications for drug therapyD M Roden
The American Journal of Cardiology|August 26, 1993
Current status of class III antiarrhythmic drug therapyD M Roden
Heart (British Cardiac Society)|August 24, 2000
Antiarrhythmic drugs: from mechanisms to clinical practiceD M Roden
Pageof 101

Showing results (51-60 of 1,010) with videos related to

Sort By:
Pageof 101
Journal of the American College of Cardiology|February 4, 2014
Atrial fibrillation genomics: time to take the next stepDan M Roden
Archives of Internal Medicine|March 1, 1985
Tocainide and mexiletine. Orally effective lidocaine analoguesD M Roden
Circulation|January 26, 2005
An underrecognized challenge in evaluating postmarketing drug safetyDan M Roden
Pacing and Clinical Electrophysiology : PACE|December 17, 2003
Antiarrhythmic drugs: past, present, and futureDan M Roden
The New England Journal of Medicine|March 5, 2004
Drug-induced prolongation of the QT intervalDan M Roden
Epilepsia|March 13, 2002
Principles in pharmacogeneticsD M Roden
Journal of Internal Medicine|December 13, 2005
Long QT syndrome: reduced repolarization reserve and the genetic linkD M Roden
The American Journal of Cardiology|November 26, 1993
Pharmacokinetics of amiodarone: implications for drug therapyD M Roden
The American Journal of Cardiology|August 26, 1993
Current status of class III antiarrhythmic drug therapyD M Roden
Heart (British Cardiac Society)|August 24, 2000
Antiarrhythmic drugs: from mechanisms to clinical practiceD M Roden
Pageof 101